Although hope has been placed on biologics for RA-ILD treatment based on their excellent efficacy against articular inflammation, the evidence suggests that the safety profile of biologics including TNF inhibitors and others is uncertain for ILD treatment. Here, TNF is linked to rheumatoid arthritis.